Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man
DR Matthews, JP Hosker, AS Rudenski, BA Naylor… - diabetologia, 1985 - Springer
The steady-state basal plasma glucose and insulin concentrations are determined by their
interaction in a feedback loop. A computer-solved model has been used to predict the …
interaction in a feedback loop. A computer-solved model has been used to predict the …
Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study
IM Stratton, AI Adler, HAW Neil, DR Matthews… - Bmj, 2000 - bmj.com
Objective: To determine the relation between exposure to glycaemia over time and the risk
of macrovascular or microvascular complications in patients with type 2 diabetes. Design: …
of macrovascular or microvascular complications in patients with type 2 diabetes. Design: …
[HTML][HTML] 10-year follow-up of intensive glucose control in type 2 diabetes
…, SK Paul, MA Bethel, DR Matthews… - New England journal …, 2008 - Mass Medical Soc
Background During the United Kingdom Prospective Diabetes Study (UKPDS), patients with
type 2 diabetes mellitus who received intensive glucose therapy had a lower risk of …
type 2 diabetes mellitus who received intensive glucose therapy had a lower risk of …
[HTML][HTML] Canagliflozin and cardiovascular and renal events in type 2 diabetes
…, W Shaw, G Law, M Desai, DR Matthews - … England Journal of …, 2017 - Mass Medical Soc
Background Canagliflozin is a sodium–glucose cotransporter 2 inhibitor that reduces glycemia
as well as blood pressure, body weight, and albuminuria in people with diabetes. We …
as well as blood pressure, body weight, and albuminuria in people with diabetes. We …
Use and abuse of HOMA modeling
TM Wallace, JC Levy, DR Matthews - Diabetes care, 2004 - Am Diabetes Assoc
Homeostatic model assessment (HOMA) is a method for assessing β-cell function and insulin
resistance (IR) from basal (fasting) glucose and insulin or C-peptide concentrations. It has …
resistance (IR) from basal (fasting) glucose and insulin or C-peptide concentrations. It has …
Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European …
…, A Tsapas, R Wender, DR Matthews - Diabetes …, 2012 - Am Diabetes Assoc
Moderate aLimited use in the US/Europe. bNot licensed in the US cPrescribing highly restricted
in the US; withdrawn in Europe. dNot licensed in Europe. eTo be available as a generic …
in the US; withdrawn in Europe. dNot licensed in Europe. eTo be available as a generic …
[HTML][HTML] The furin cleavage site in the SARS-CoV-2 spike protein is required for transmission in ferrets
…, M Osborn, M Giacca, AD Davidson, DA Matthews… - Nature …, 2021 - nature.com
SARS-CoV-2 entry requires sequential cleavage of the spike glycoprotein at the S1/S2 and
the S2ʹ cleavage sites to mediate membrane fusion. SARS-CoV-2 has a polybasic insertion (…
the S2ʹ cleavage sites to mediate membrane fusion. SARS-CoV-2 has a polybasic insertion (…
Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the …
…, AL Peters, A Tsapas, R Wender, DR Matthews - Diabetes …, 2015 - Am Diabetes Assoc
In 2012, the American Diabetes Association (ADA) and the European Association for the Study
of Diabetes (EASD) published a position statement on the management of hyperglycemia …
of Diabetes (EASD) published a position statement on the management of hyperglycemia …
Publication bias in clinical research
In a retrospective survey, 487 research projects approved by the Central Oxford Research
Ethics Committee between 1984 and 1987, were studied for evidence of publication bias. As …
Ethics Committee between 1984 and 1987, were studied for evidence of publication bias. As …
Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study
…, IM Stratton, HAW Neil, JS Yudkin, DR Matthews… - Bmj, 2000 - bmj.com
Objective: To determine the relation between systolic blood pressure over time and the risk
of macrovascular or microvascular complications in patients with type 2 diabetes. Design: …
of macrovascular or microvascular complications in patients with type 2 diabetes. Design: …